News Biogen takes on Tecfidera adherence issues Company hopes to coach patients with stomach side-effects.
News Celgene baffles market with Crohn's drug data Analysts left guessing from snippet of early phase data.
News Shire buys rights to Pfizer gastrointestinal drug Shire has bought rights to PF-00547659 for an undisclosed sum.
News Biosimilar switching not suitable for all patients Antibodies against originator will also target biosimilar.
